← Eichor
Study identifier: NCT07237620 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Different Intracanal Medicaments on Periapical Lesion Healing

Condition: Periapical Lesion Healing · Apical Periodontitis  ·  Sponsor: Mustafa Kemal University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

This study is planned to evaluate the effects of two different intracanal medicaments-calcium hydroxide and diclofenac sodium-on periapical healing following endodontic retreatment. Fifty-four patients will be included and randomly assigned into two groups according to the type of medicament used. All procedures will be performed by a single experienced endodontist under standardized clinical conditions. Periapical lesion healing will be assessed radiographically at baseline and after 12 months using fractal analysis to quantitatively evaluate bone regeneration. The primary outcome will be the change in the fractal dimension values between the initial and follow-up radiographs.

This description comes directly from the study's public registry record.

Talk to the study team

Merve Sarı, DDS,MSc  ·  +905546430401  ·  sarimerve94@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

Merve SarıHatay, Antakya, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07237620